- Home
- NCL vs HBIO Comparison
NCL vs HBIO Comparison
Compare NCL & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCL
- HBIO
- Stock Information
- Founded
- NCL 2013
- HBIO 1901
- Country
- NCL United States
- HBIO United States
- Employees
- NCL N/A
- HBIO N/A
- Industry
- NCL
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- NCL
- HBIO Industrials
- Exchange
- NCL Nasdaq
- HBIO Nasdaq
- Market Cap
- NCL 30.7M
- HBIO 24.6M
- IPO Year
- NCL 2023
- HBIO 2000
- Fundamental
- Price
- NCL $0.12
- HBIO $0.44
- Analyst Decision
- NCL
- HBIO Buy
- Analyst Count
- NCL 0
- HBIO 3
- Target Price
- NCL N/A
- HBIO $2.50
- AVG Volume (30 Days)
- NCL 2.6M
- HBIO 1.1M
- Earning Date
- NCL 11-18-2025
- HBIO 11-06-2025
- Dividend Yield
- NCL N/A
- HBIO N/A
- EPS Growth
- NCL N/A
- HBIO N/A
- EPS
- NCL N/A
- HBIO N/A
- Revenue
- NCL $12,009,378.00
- HBIO $88,750,000.00
- Revenue This Year
- NCL N/A
- HBIO N/A
- Revenue Next Year
- NCL N/A
- HBIO $7.02
- P/E Ratio
- NCL N/A
- HBIO N/A
- Revenue Growth
- NCL N/A
- HBIO N/A
- 52 Week Low
- NCL $0.12
- HBIO $0.28
- 52 Week High
- NCL $1.52
- HBIO $2.82
- Technical
- Relative Strength Index (RSI)
- NCL 47.66
- HBIO 43.42
- Support Level
- NCL $0.12
- HBIO $0.43
- Resistance Level
- NCL $1.03
- HBIO $0.47
- Average True Range (ATR)
- NCL 0.02
- HBIO 0.02
- MACD
- NCL 0.03
- HBIO -0.00
- Stochastic Oscillator
- NCL 0.99
- HBIO 14.39
About NCL Northann Corp.
Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.